The ability to diagnose diseases quickly, accurately and inexpensively can make a huge difference in global health, but so far our diagnostic methods are all fairly involved, not to mention costly and time-consuming. A team of researchers from UC Berkeley, Dublin CityUniversity and Universidad de Valpairaiso has made an astounding breakthrough in the field of microfluidics that could revolutionize the way diseases are diagnosed and treated in remote locations and third-world countries. The Self-powered Integrated Microfluidic Blood Analysis System (or SIMBAS) is basically a diagnostic lab on a single chip that diagnoses blood diseases in a matter of minutes without the use of electricity, chemicals or any special equipment.